CinCor Pharma
Clinical-stage biopharmaceutical company developing baxdrostat (CIN-107), a highly selective aldosterone synthase inhibitor for the treatment of hypertension and other cardiovascular conditions.
Website
https://www.cincor.comLocation
Waltham, Massachusetts, USA
Founded
2018
Investors
1
Categories
biotech, pharmaceuticals, cardiovascular, hypertension, therapeutics
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Sofinnova Partners | Paris, France | biotech-focused | seedseries-a+3 | 23 |
